1. Weber, Sarah, Koschade, Sebastian E, Hoffmann, Christopher M, Glimm, Hanno, Ball, Claudia R. 2019. The notch target gene HEYL modulates metastasis forming capacity of colorectal cancer patient-derived spheroid cells in vivo. In BMC cancer, 19, 1181. doi:10.1186/s12885-019-6396-4. https://pubmed.ncbi.nlm.nih.gov/31796022/
2. Han, Liangfeng, Korangath, Preethi, Nguyen, Nguyen K, Romer, Lewis, Sukumar, Saraswati. 2021. HEYL Regulates Neoangiogenesis Through Overexpression in Both Breast Tumor Epithelium and Endothelium. In Frontiers in oncology, 10, 581459. doi:10.3389/fonc.2020.581459. https://pubmed.ncbi.nlm.nih.gov/33520697/
3. Sun, Hao, Liu, Fangzhou, Lin, Zhencan, Zhang, Zhiqi, Ma, Ruofan. 2023. Silencing of NOTCH3 Signaling in Meniscus Smooth Muscle Cells Inhibits Fibrosis and Exacerbates Degeneration in a HEYL-Dependent Manner. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 10, e2207020. doi:10.1002/advs.202207020. https://pubmed.ncbi.nlm.nih.gov/37026620/
4. Jalali, Ali, Bassuk, Alexander G, Kan, Lixin, McGuire, Tammy, Kessler, John A. 2011. HeyL promotes neuronal differentiation of neural progenitor cells. In Journal of neuroscience research, 89, 299-309. doi:10.1002/jnr.22562. https://pubmed.ncbi.nlm.nih.gov/21259317/
5. Fadel, Hewida H, Ahmed, Mohammad Abd El-Rahman, Gharbeya, Kareem Mahamoud, Roushdy, Mohamed N, Almiry, Reda. 2022. Partial-Methylated HeyL Promoter Predicts the Severe Illness in Egyptian COVID-19 Patients. In Disease markers, 2022, 6780710. doi:10.1155/2022/6780710. https://pubmed.ncbi.nlm.nih.gov/35655915/